Use of biologics in rheumatoid arthritis: where are we going?

Use of biologics in rheumatoid arthritis: where are we going?

Item
http://www.wikidata.org/entity/Q36588861
Quality and completeness of utilisation data on biological agents across European countries: tumour necrosis factor alpha inhibitors as a case study.Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.Evolution of clinical pharmacy in the practice of rheumatology.The Burden of Rheumatic Diseases: An Analysis of an Italian Administrative Database.Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression.Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey.Biological therapy in arthritis patients with hepatitis B or C infection: a multicenter retrospective case series.Cost–effectiveness of tumor necrosis factor-α antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
P2860

Use of biologics in rheumatoid arthritis: where are we going?

Item
http://www.wikidata.org/entity/Q36588861
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Use of biologics in rheumatoid arthritis: where are we going?
@ast
Use of biologics in rheumatoid arthritis: where are we going?
@en
type
label
Use of biologics in rheumatoid arthritis: where are we going?
@ast
Use of biologics in rheumatoid arthritis: where are we going?
@en
prefLabel
Use of biologics in rheumatoid arthritis: where are we going?
@ast
Use of biologics in rheumatoid arthritis: where are we going?
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Use of biologics in rheumatoid arthritis: where are we going?
@en
P2093
P304
P31
P356
P433
P478
P577
P698